Showing results (291-300 of 327) with videos related to

Sort By:
Pageof 33
Cancer Science|August 5, 2011
Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancerShingo Kato, Kensuke Kubota, Takeshi Shimamura, et al.
Clinical Colorectal Cancer|June 13, 2015
Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201)Sotaro Sadahiro, Satoshi Morita, Kazuaki Sasaki, et al.
The Journal of Invasive Cardiology|February 2, 2020
Investigation of Computed-Tomography Based Predictors of Acute Stroke Related to Transcatheter Aortic Valve Replacement: Aortic Wall Plaque Thickness Might be a Predictive Parameter of StrokeMasaki Miyasaka, Rahul P Sharma, Yoshio Maeno, et al.
International Journal of Clinical Oncology|June 4, 2024
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201)Yutaka Ogata, Sotaro Sadahiro, Kazuhiro Sakamoto, et al.
International Journal of Hematology|January 24, 2016
A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide surveyRika Sakai, Masataka Taguri, Kumi Oshima, et al.
Cardiovascular Research|September 6, 2014
Decreased serum osmolality promotes ductus arteriosus constrictionRika Aoki, Utako Yokoyama, Yasuhiro Ichikawa, et al.
Scientific Reports|December 15, 2016
NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitisShigehiro Itani, Toshio Watanabe, Yuji Nadatani, et al.
Plos One|February 21, 2019
Involvement of gliadin, a component of wheat gluten, in increased intestinal permeability leading to non-steroidal anti-inflammatory drug-induced small-intestinal damageSunao Shimada, Tetsuya Tanigawa, Toshio Watanabe, et al.
Leukemia Research|September 10, 2015
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapyKazuho Miyashita, Naoto Tomita, Masataka Taguri, et al.
The Lancet. Gastroenterology & Hepatology|August 18, 2020
Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trialTakaomi Kessoku, Kento Imajo, Takashi Kobayashi, et al.
Pageof 33